Targeted Potassium Levels for Prevention of ICD Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1200 participants.

Also called NCT03833089

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03833089
Other papers using this trial's data
  • Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias The New England journal of medicine, 2025-11-20 DOI, PubMed 40879429

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03833089. Randomized; no masking; primary purpose prevention. Start 2019-03-01 (actual); primary completion 2025-05-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Targeted Potassium Levels for Prevention of ICD Therapy
Condition
Ventricular Arrhythmias and Cardiac Arrest
Condition
Implantable Defibrillator User
Condition
Hypokalemia
Condition
Hyperkalemia
Condition
Ventricular Tachycardia
Intervention (Combination product)
Targeted serum potassium level
Lead sponsor
Copenhagen University Hospital, Rigshospitalet (class: other)
Collaborator
Herlev and Gentofte Hospital (class: other)

Record details

Record id
cardio:ct-nct03833089
Content hash
daea5cd22f50ca8b0bbf32b3dbec82410f4dd04daac38060e4738db46e72ef13